Overview

Anti-infection of Low-does IL-2 in SLE

Status:
Completed
Trial end date:
2017-08-30
Target enrollment:
Participant gender:
Summary
The objective of this clinical study is to evaluate the potential effect of anti-infection of low-does IL-2 in patients with SLE.
Phase:
N/A
Details
Lead Sponsor:
Peking University People's Hospital
Treatments:
Glucocorticoids
Interleukin-2